Joshua Meyer, MD
Assistant Physician in Pediatrics, Division of Emergency Medicine
Instructor of Pediatrics (Part-time), Harvard Medical School
Image
Email
Email Me
NPI
1164953733
Joshua Meyer, MD
Assistant Physician in Pediatrics, Division of Emergency Medicine
Instructor of Pediatrics (Part-time), Harvard Medical School
Medical Services
Languages
English
Certifications
American Board of Pediatrics (General)
Publications
Racial/Ethnic Differences and Effects of Clinical/Socioeconomic Factors on Time from Diagnosis to Treatment in Pancreatic Cancer. View Abstract
Palliative Care and End-of-Life Care in Metastatic Pancreatic Cancer. View Abstract
Survival outcomes of adjuvant treatment in upstaged clinical T2N0 rectal cancer: are we underutilizing therapy? View Abstract
CT-Guided Adaptive Radiotherapy for the Treatment of Technically Challenging Oligometastatic Disease: A Case Report. View Abstract
Adaptive Stereotactic Body Radiation Therapy in the Management of Oligometastatic Uterine Leiomyosarcoma: A Clinical Case Report. View Abstract
Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery. View Abstract
Factors Associated With Racial and Ethnic Disparities in Locally Advanced Rectal Cancer Outcomes. View Abstract
NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancer. View Abstract
Survival and Toxicity in Patients With Unresectable or Inoperable Biliary Tract Cancers With Ablative Radiation Therapy Versus Nonablative Chemoradiation. View Abstract
Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer. View Abstract
Understanding the Challenges Faced by Esophageal and Gastroesophageal Junction Cancer Survivors. View Abstract
Comparing Lifestyle Modifications and the Magnitude of Their Associated Benefit on Cancer Mortality. View Abstract
Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials. View Abstract
The Role of Dose Escalation in Pancreatic Cancer: Go Big or Go Home? View Abstract
Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials: Analysis of RTOG 9811 and RTOG 0529. View Abstract
Real-world Use of Radiation for Newly Diagnosed Brain Metastases in Patients With ALK-positive Lung Cancer Receiving First-line ALK Inhibitor. View Abstract
Delineating the RAS Conformational Landscape. View Abstract
The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumors. View Abstract
Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers. View Abstract
Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology. View Abstract
The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials. View Abstract
Initial Clinical Experience With Novel Directional Low-Dose Rate Brachytherapy for Retroperitoneal Sarcoma. View Abstract
A Case of Radiation Recall Myositis and Neuropathy in Locally Advanced Rectal Cancer. View Abstract
Neoadjuvant Chemoradiation Impacts the Prognostic Effect of Surgical Margin Status in Pancreatic Adenocarcinoma. View Abstract
ASO Author Reflections: Neoadjuvant Chemoradiation Impacts the Prognostic Effect of Surgical Margin Status in Pancreatic Adenocarcinoma. View Abstract
MRI-Guided Focused Ultrasound of Osseous Metastases: Treatment Parameters Associated With Successful Pain Reduction. View Abstract
Pancreatic cancer in the era of COVID-19 pandemic: Which one is the lesser of two evils? View Abstract
Predicting positive peritoneal cytology in pancreatic cancer. View Abstract
Feasibility of Fitness Tracker Usage to Assess Activity Level and Toxicities in Patients With Colorectal Cancer. View Abstract
Impact of Clinical Markers of Nutritional Status and Feeding Jejunostomy Use on Outcomes in Esophageal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy. View Abstract
Practical Clinical Implementation of the Special Physics Consultation Process in the Re-irradiation Environment. View Abstract
Pelvic Reirradiation Utilizing Pulsed Low-dose Rate Radiation Therapy. View Abstract
Patterns of Failure and Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation. View Abstract
Toxicity and outcomes in older versus younger patients treated with trimodality therapy for locally advanced rectal cancer. View Abstract
Predictors of Distant Recurrence Following Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer. View Abstract
Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704. View Abstract
Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients. View Abstract
Treatment-related toxicity and outcomes in older versus younger patients with esophageal cancer treated with neoadjuvant chemoradiation. View Abstract
Impact of PET/CT for Restaging Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation. View Abstract
Dose Escalation in Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Meta-Analysis. View Abstract
External beam radiation therapy (EBRT) for asymptomatic bone metastases in patients with solid tumors reduces the risk of skeletal-related events (SREs). View Abstract
Concurrent chemoradiation for resected gall bladder cancers and cholangiocarcinomas. View Abstract
Predictive Value of Leukocyte- and Platelet-Derived Ratios in Rectal Adenocarcinoma. View Abstract
Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704. View Abstract
Mismatch Repair Deficiency Testing in Patients With Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults. View Abstract
Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer. View Abstract
Local Control and Toxicity of External Beam Reirradiation With a Pulsed Low-dose-rate Technique. View Abstract
Deviations From Standard Chemoradiation Among Early-Stage Anal Cancer Patients. View Abstract
Trends in intensity modulated radiation therapy use for locally advanced rectal cancer at National Comprehensive Cancer Network centers. View Abstract
Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection. View Abstract
Optimal Use of Combined Modality Therapy in the Treatment of Esophageal Cancer. View Abstract
Tissue TGF-ß expression following conventional radiotherapy and pulsed low-dose-rate radiation. View Abstract
Splenic irradiation for splenomegaly: A systematic review. View Abstract
Disparities in the Local Management of Breast Cancer in the US according to Health Insurance Status. View Abstract
Absence of Pathological Proof of Cancer Associated with Improved Outcomes in Early-Stage Lung Cancer. View Abstract
In regard to Wu and Vapiwala et al. View Abstract
Risk of radiation pneumonitis in patients receiving taxane-based trimodality therapy for locally advanced esophageal cancer. View Abstract
Dosimetric and delivery efficiency investigation for treating hepatic lesions with a MLC-equipped robotic radiosurgery-radiotherapy combined system. View Abstract
Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. View Abstract
Young Age Increases Risk of Lymph Node Positivity in Early-Stage Rectal Cancer. View Abstract
Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas. View Abstract
Patterns and predictors of failure following tri-modality therapy for locally advanced esophageal cancer. View Abstract
Dosimetric predictors of hematologic toxicity in patients undergoing concurrent gemcitabine-based chemoradiation for localized pancreatic cancer. View Abstract
What Are Medical Students in the United States Learning About Radiation Oncology? Results of a Multi-Institutional Survey. View Abstract
Association of treatment factors with surgical outcomes in tri-modality therapy for esophageal cancer. View Abstract
Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. View Abstract
Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer. View Abstract
Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer. View Abstract
Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial results. View Abstract
HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer. View Abstract
Neoadjuvant chemoradiation and duration of chemotherapy before surgical resection for pancreatic cancer: does time interval between radiotherapy and surgery matter? View Abstract
Women at increased risk for cardiac toxicity following chemoradiation therapy for esophageal carcinoma. View Abstract
Impact of preoperative therapy on patterns of recurrence in pancreatic cancer. View Abstract
When less is more, when less is less: local excision in early rectal cancer. View Abstract
Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry. View Abstract
Radiation therapy toxicity to the skin. View Abstract
The effect of radiation therapy on normal tissue function. View Abstract